Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Split-face, Randomized, Comparative Trial on the Efficacy of Two Hyaluronic Acid Products (Restylane + Lidocaine and Restylane Lyft) for the Treatment of Nasolabial Folds

NCT04174131 is registered in ClinicalTrials.gov with Erevna Innovations Inc. as lead sponsor.

NCT NCT04174131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04174131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Split-face, Randomized, Comparative Trial on the Efficacy of Two Hyaluronic Acid Products (Restylane + Lidocaine and Restylane Lyft) for the Treatment of Nasolabial Folds
Lead sponsor
Erevna Innovations Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 13, 2019
Completion date
February 12, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wrinkles such as nasolabial folds